Intended for US audience only
For people with malignant pleural mesothelioma (MPM)
"I HAVE MORE LIVING TO DO"
Optune Lua® was the first FDA-approved treatment* for MPM in over 15 years.
Actor portrayal
Optune Lua in addition to chemotherapy is approved to treat people with unresectable, locally advanced or metastatic, malignant pleural mesothelioma. To find out what these words mean, click here.
A clinical study showed that using Optune Lua in addition to chemotherapy provided†
*FDA approved under the Humanitarian Device Exemption pathway.
†In a clinical study, Optune Lua was used with chemotherapy (pemetrexed and platinum-based chemotherapy) in 80 untreated patients with unresectable (unable to be removed via surgery) malignant pleural mesothelioma.
‡Pemetrexed and platinum-based chemotherapy.
- Optune Lua is not a medicine and does not enter the bloodstream
- When used with chemotherapy,‡ the most common device-related side effect was skin irritation
- In the clinical study, the only side effect related to Optune Lua use was skin irritation seen in 71% of people (66% mild-to-moderate and 5% severe)
- Most people were able to treat their skin irritation with a prescription medication applied to the skin that is provided by their doctor.
Designed for your everyday life
Optune Lua is wearable and portable–so continuous treatment with TTFields can be received almost anywhere.
Committed to supporting you
With MyNovocure, you have a team of experts ready to support you throughout your treatment journey. Your team is prepared to help with reimbursement assistance, device setup and questions, product education, and troubleshooting. You can count on the MyNovocure team to be there for you when you need them 24/7.